Tissue shaping device

Information

  • Patent Grant
  • 12016538
  • Patent Number
    12,016,538
  • Date Filed
    Tuesday, June 15, 2021
    3 years ago
  • Date Issued
    Tuesday, June 25, 2024
    5 months ago
Abstract
In one embodiment, the present invention relates to a tissue shaping device adapted to be disposed in a vessel near a patient's heart to reshape the patient's heart. Such tissue shaping device can include an expandable proximal anchor; a proximal anchor lock adapted to lock the proximal anchor in an expanded configuration; an expandable distal anchor; a distal anchor lock adapted to lock the distal anchor in an expanded configuration; and a connector disposed between the proximal anchor and the distal anchor, the connector having a substantially non-circular cross-section.
Description
BACKGROUND OF THE INVENTION

This invention relates generally to devices and methods for shaping tissue by deploying one or more devices in body lumens adjacent to the tissue. One particular application of the invention relates to a treatment for mitral valve regurgitation through deployment of a tissue shaping device in the patient's coronary sinus or great cardiac vein.


The mitral valve is a portion of the heart that is located between the chambers of the left atrium and the left ventricle. When the left ventricle contracts to pump blood throughout the body, the mitral valve closes to prevent the blood being pumped back into the left atrium. In some patients, whether due to genetic malformation, disease or injury, the mitral valve fails to close properly causing a condition known as regurgitation, whereby blood is pumped into the atrium upon each contraction of the heart muscle. Regurgitation is a serious, often rapidly deteriorating, condition that reduces circulatory efficiency and must be corrected.


Two of the more common techniques for restoring the function of a damaged mitral valve are to surgically replace the valve with a mechanical valve or to suture a flexible ring around the valve to support it. Each of these procedures is highly invasive because access to the heart is obtained through an opening in the patient's chest. Patients with mitral valve regurgitation are often relatively frail thereby increasing the risks associated with such an operation.


One less invasive approach for aiding the closure of the mitral valve involves the placement of a tissue shaping device in the cardiac sinus, a vessel that passes adjacent the mitral valve annulus. (As used herein, “coronary sinus” refers to not only the coronary sinus itself, but also to the venous system associated with the coronary sinus, including the great cardiac vein.) The tissue shaping device is designed to reshape the vessel and surrounding valve tissue to reshape the valve annulus and other components, thereby promoting valve leaflet coaptation. This technique has the advantage over other methods of mitral valve repair because it can be performed percutaneously without opening the chest wall. Examples of such devices are shown in U.S. application Ser. No. 10/142,637, “Body Lumen Device Anchor, Device and Assembly” filed May 8, 2002, now U.S. Pat. No. 6,824,562; U.S. application Ser. No. 10/331,143, “System and Method to Effect the Mitral Valve Annulus of a Heart” filed Dec. 26, 2002, now U.S. Pat. No. 6,793,673; U.S. application Ser. No. 10/429,172, “Device and Method for Modifying the Shape of a Body Organ,” filed May 2, 2003; and U.S. application Ser. No. 10/742,600 filed Dec. 19, 2003.


SUMMARY OF THE INVENTION

Tissue shaping devices can encounter material stress while in storage, during deployment and after implant. Repeated stress can lead to material fatigue and breakage. The present invention provides a tissue shaping device with improved stress response characteristics.


One aspect of the invention provides a tissue shaping device adapted to be disposed in a vessel near a patient's heart to reshape the patient's heart. The tissue shaping device has an expandable proximal anchor; a proximal anchor lock adapted to lock the proximal anchor in an expanded configuration; an expandable distal anchor; a distal anchor lock adapted to lock the distal anchor in an expanded configuration; and a connector disposed between the proximal anchor and the distal anchor, with the connector having a substantially non-circular cross-section, such as a substantially rectangular or substantially oval cross-section.


In some embodiments, the distal anchor lock includes a bend in the connector and, optionally, a compliant element adjacent the bend in the connector, with at least the compliant element being adapted to change shape during a distal anchor locking operation. In some embodiments the distal anchor lock has an anchor lock element adapted to move with respect to the connector as the distal anchor expands.


In some embodiments, the connector is a first connector, and the device also has a second connector extending between the proximal and distal anchors. The distal anchor lock may make up at least part of the wire element. The second connector can be adapted to provide fatigue resistance.


In some embodiments, the distal anchor has a crimp and a wire element extending from the crimp, the wire element having a strain relief portion extending distal of the crimp to form a bend extending substantially below a plane defined by the crimp. The distal anchor wire element may also have a vessel engagement portion extending proximally from the strain relief portion and away from the crimp and a lock portion extending from the vessel engagement portion to form part of the distal lock.


In further embodiments, the proximal anchor can include a crimp and a wire element extending from the crimp, with the wire element having a strain relief portion extending distal of the crimp to form a bend extending substantially below a plane defined by the crimp. The proximal anchor wire element further may also have a vessel engagement portion extending proximally from the strain relief portion and away from the crimp and a lock portion extending from the vessel engagement portion and forming part of the proximal lock.


Another aspect of the invention provides a tissue shaping device adapted to be disposed in a vessel near a patient's heart to reshape the patient's heart. The tissue shaping device may include an expandable proximal anchor, with the proximal anchor having a crimp and a wire element extending from the crimp and the wire element having a strain relief portion extending distal of the crimp to form a bend extending substantially below a plane defined by the crimp. The tissue shaping device may also have an expandable distal anchor, with the distal anchor comprising a crimp and a wire element extending from the crimp and the wire element having a strain relief portion extending distal of the crimp to form a bend extending substantially below a plane defined by the crimp. The tissue shaping device may also have a connector extending between the proximal anchor crimp and the distal anchor connector crimp.


In some embodiments, the proximal anchor wire element further includes a vessel engagement portion extending proximally from the strain relief portion and away from the crimp, a vessel engagement portion extending proximally from the strain relief portion and away from the crimp, a proximal anchor lock adapted to lock the proximal anchor in an expanded configuration, and/or a distal anchor lock adapted to lock the distal anchor in an expanded configuration.


INCORPORATION BY REFERENCE

All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.





BRIEF DESCRIPTION OF THE DRAWINGS

The novel features of the invention are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:



FIG. 1 is a schematic view of a human heart with the atria removed.



FIG. 2 is a schematic view of a human heart showing the deployment of a tissue shaping device in the coronary sinus.



FIG. 3 is a perspective view of a tissue shaping device according to one embodiment of this invention.



FIG. 4 is another perspective view of the tissue shaping device of FIG. 3.



FIG. 5 is side elevational view of the tissue shaping device of FIGS. 3 and 4.



FIG. 6 is a perspective view showing the device of FIG. 3 in an unexpanded configuration and in a partially expanded configuration.





DETAILED DESCRIPTION OF THE INVENTION


FIG. 1 is a superior view of a heart 100 with the atria removed. As pictured, the heart comprises several valves including mitral valve 102, pulmonary valve 104, aortic valve 106 and tricuspid valve 108. Mitral valve 102 includes anterior cusp 110, posterior cusp 112 and annulus 114. Annulus 114 encircles cusps 110 and 112 and functions to maintain their respective spacing to ensure complete mitral valve closure during left ventricular contractions of the heart 100. As illustrated, coronary sinus 116 partially encircles mitral valve 102 and is adjacent to mitral valve annulus 114. Coronary sinus 116 is part of the venous system of heart 100 and extends along the AV groove between the left atrium and the left ventricle. This places coronary sinus 116 essentially within the same plane as mitral valve annulus 114, making coronary sinus 116 available for placement of shaping device 200 in order to effect mitral valve geometry and to restore proper valve function.



FIG. 2 illustrates one possible embodiment of an implantable shaping device 200, which is deployable in coronary sinus 116 or other body lumen. As illustrated in FIG. 2, device 200 generally comprises an elongated connector 220 disposed between a distal anchor 240 and a proximal anchor 260. Both distal anchor 240 and proximal anchor 260 are shown in their deployed (i.e. expanded) configuration in FIG. 2, securely positioned within the coronary sinus 116. FIG. 2 further depicts, in phantom, a deployment system 300 comprising catheter 302 for delivering and positioning shaping device 200 in the coronary sinus 116. Further details of the delivery system may be found in U.S. application Ser. Nos. 10/946,332 and 10/945,855.



FIGS. 3-5 show one embodiment of a tissue shaping device 400 with proximal anchor 402 and distal anchor 404 in their expanded and locked configurations. In this embodiment, proximal anchor 402 is made from a shape memory metal wire (such as Nitinol) extending from a crimp 406. Stress relief portions 408 of the wire extend distal to crimp 406; the purpose of these stress relief features will be discussed below with reference to FIG. 6. The wire extends upward from stress relief portions 408 to form vessel engagement portions 410 which cross to form a FIG. 8 pattern, as shown. Vessel engagement portions 410 and crimp 406 engage the inner wall of the coronary sinus or other vessel in which the device is implanted. The wire also forms a lock loop 412 which interacts with an arrowhead-shaped element 414 extending from the proximal end of the crimp to form the proximal anchor lock. Actuation of the proximal anchor lock is described in U.S. Application Ser. No. 10/946,332, now U.S. Pat. No. 7,837,729, and Ser. No. 10/945,855, now U.S. Pat. No. 8,182,529.


Likewise, distal anchor is made from a shape memory wire 416 extending from a crimp 418. Stress relief portions 420 of the wire extend distal to crimp 418. Wire 416 extends upward from stress relief portions 420 to form vessel engagement portions 422 which cross to form a FIG. 8 pattern, as shown. Vessel engagement portions 422 and crimp 418 engage the inner wall of the coronary sinus or other vessel in which the device is implanted. Wire 416 also forms a lock loop 424.


Extending between anchors 402 and 404 are a substantially flat connector 426 and a wire connector 428. In this embodiment, connectors 426 and 428 are both made of shape memory metal, such as Nitinol. When device 400 is deployed within the coronary sinus or other vessel, the distal anchor 404 is deployed from the delivery catheter first, then expanded and locked to maintain its position within the vessel. A proximal cinching force is then applied on the distal anchor from, e.g., a tether attached to arrowhead element 414 until an appropriate amount of reshaping of the mitral valve or other tissue has occurred (as determined, e.g., by viewing blood flow with fluoroscopy, ultrasound, etc.). While maintaining the cinching force, proximal anchor 402 is deployed from the delivery catheter, expanded and locked in the expanded configuration. The device 400 may then be released from the delivery system's tether. By spanning the distance between proximal anchor 402 and distal anchor 404, connectors 426 and 428 maintain the reshaping force on the tissue.


When deployed in the coronary sinus to reshape the mitral valve annulus, the tissue shaping devices of this invention are subjected to cyclic bending and tensile loading as the patient's heart beats. Device 400 differs from prior tissue shaping devices by changing the cross-sectional profile of the connector, in this illustration by making connector 426 substantially flat. This shape provides improved fatigue resistance over prior devices whose wire connectors had a round profile. In addition, the flat shape of connector 426 helps device 400 to orient itself within the vessel during the deployment process. In alternative embodiments, connector 426 may have a more round shape, with, e.g., an oval cross-section or other non-circular cross-section instead of a rectangular cross-section.


Prior to use, tissue shaping devices such as those shown in FIGS. 3-5 may be stored in cartridges or other containers, such as described in U.S. application Ser. Nos. 10/946,332 and 10/945,855, then delivered to the coronary sinus or other vessel in a delivery catheter, as shown in FIG. 2. During storage and delivery, the device may be compressed in the directions shown by the arrows in FIG. 6 from an unstressed expanded shape into an unexpanded configuration, such as the configuration shown in phantom in FIG. 6. There are two aspects of stresses experienced by the device. In one aspect stress may be imparted while the device is collapsed for storage and delivery. While collapsed it is possible that the change of shape from unstressed configuration to collapsed condition creates an area of higher stress. Anchor wire forms are designed with stress reliving element (420) to reduce this type of stress on implant while in storage or during deployment. Another aspect of stress on implant happens when it is deployed, locked, and detached from the delivery catheter. This type of stress comes from the repeated motion (fatigue) of heart increasing bending stress on implant. This could result in implant fracture. The connector element design (426) with flat ribbon provides resistance to this bending stress thus reducing chances of fatigue fracture. In this embodiment, therefore, the device is provided with stress relief features. Bent portions 408 of the proximal anchor wire provide extra stress relief while the device is in storage and relieves material stress on the wire that would otherwise be present where the wire emerges from crimp 406. Similar stress relief bends 420 in distal anchor wire 416 serve a similar function.



FIG. 6 shows device 400 in a compressed storage configuration (shown in phantom) and in a partially expanded but not yet locked configuration. After emerging from the delivery catheter, the shape memory characteristics of anchors 402 and 404 will cause them to expand to, e.g., the configuration shown in solid line in FIG. 6. After the user confirms that the device is in the desired position, the user may then employ the device delivery system (such as that described in U.S. application Ser. Nos. 10/946,332 and 10/945,855) to lock the distal anchor by moving lock loop 424 distally with respect to the connector. Distal movement of lock loop 424 beyond the position shown in FIG. 6 will cause bent portions 430 and 432 of connectors 426 and 428, respectively, to move toward each other, permitting lock loop to pass over them to the position shown in FIG. 1, thereby locking the distal anchor in an expanded configuration. After placement of the proximal anchor in its desired position (after, e.g., application of a proximally directed cinching force), proximal anchor lock loop 412 may be advanced distally over arrowhead element 414 to lock the proximal anchor in an expanded configuration.


While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.

Claims
  • 1. A tissue shaping device, comprising: a proximal anchor;a distal anchor;a first connector extending between the proximal anchor and the distal anchor, the first connector having, in a cross section orthogonal to a longitudinal axis of the first connector, a non-circular profile that includes a flat surface; anda second connector extending between the proximal anchor and the distal anchor.
  • 2. The tissue shaping device of claim 1, wherein, in the cross section, the non-circular profile includes a second flat surface.
  • 3. The tissue shaping device of claim 2, wherein the first connector, in the cross section, has a rectangular profile.
  • 4. The tissue shaping device of claim 1, wherein the first connector has, in every cross section that is orthogonal to the longitudinal axis of the first connector between the proximal and distal anchors, a non-circular profile.
  • 5. The tissue shaping device of claim 4 wherein, in every cross section, the non-circular profile includes a flat surface.
  • 6. The tissue shaping device of claim 5 wherein in every cross section, the non-circular profile includes a second flat surface.
  • 7. The tissue shaping device of claim 6, wherein in every cross section, the non-circular profile is rectangular.
  • 8. The tissue shaping device of claim 5, further comprising a lock adapted to lock the distal anchor in a locked configuration, wherein the lock comprises a bend in the first connector.
  • 9. The tissue shaping device of claim 8, wherein the lock further comprises a bend in the second connector.
  • 10. The tissue shaping device of claim 1, wherein the second connector has, in a cross section that is orthogonal to a longitudinal axis of the second connector, a circular profile.
  • 11. The tissue shaping device of claim 10, wherein the second connector has, in every cross section that is orthogonal to the longitudinal axis of the second connector, a circular profile.
  • 12. The device of claim 1, wherein the first and second connectors each have a fixed length between the distal and proximal anchors.
  • 13. A tissue shaping device adapted to be disposed in a vessel and reshape a patient's heart, comprising: an expandable first anchor having an expanded configuration and a collapsed configuration;an expandable second anchor having an expanded configuration and a collapsed configuration; anda connector disposed between the first anchor and the second anchor,wherein at least one of the first and second anchors comprises a wire that has a collapsed position when the respective anchor is in the collapsed configuration and an expanded position when the respective anchor is in the expanded configuration,wherein the wire comprises a strain relief portion disposed at an end of the anchor, the strain relief portion comprising a bend about which the wire deforms when the respective anchor deforms from the expanded configuration to the collapsed configuration, wherein in the strain relief portion the wire extends below an axis of the connector.
  • 14. The tissue shaping device of claim 13, wherein the wire, after extending below the axis of the connector, extends back towards the axis of the connector.
  • 15. The tissue shaping device of claim 14, wherein after extending back towards the axis of the connector, the wire extends above the axis of the connector.
  • 16. The tissue shaping device of claim 13, further comprising a first lock to lock the first anchor in the expanded configuration.
  • 17. The tissue shaping device of claim 13, further comprising a second lock to lock the second anchor in the expanded configuration.
  • 18. The tissue shaping device of claim 13, wherein the first and second anchors each comprise a wire that has a collapsed position when the respective anchor is in the collapsed configuration and an expanded position when the respective anchor is in the expanded configuration, wherein each of the wires comprise a strain relief portion disposed at an end of the anchor, the strain relief portion comprising a bend about which the wire deforms when the respective anchor deforms from the expanded configuration to the collapsed configuration, wherein in the strain relief portions the wires extend below an axis of the connector.
  • 19. The tissue shaping device of claim 13, wherein the strain relief portion comprises a bend in the wire.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 16/275,920 filed Feb. 14, 2019, which is a continuation of U.S. application Ser. No. 15/465,253, filed Mar. 21, 2017, now U.S. Pat. No. 10,206,778, which is a continuation of U.S. application Ser. No. 15/136,739, filed Apr. 22, 2016, now U.S. Pat. No. 9,597,186; which is a continuation of U.S. application Ser. No. 14/642,476, filed Mar. 9, 2015, now U.S. Pat. No. 9,320,600; which is a continuation of U.S. application Ser. No. 12/907,907, filed Oct. 19, 2010, now U.S. Pat. No. 8,974,525; which is a continuation of U.S. application Ser. No. 12/060,781, filed Apr. 1, 2008, now U.S. Pat. No. 7,828,842; which is a continuation of U.S. application Ser. No. 11/275,630, filed Jan. 19, 2006, now U.S. Pat. No. 7,351,260; which is a continuation-in-part of U.S. application Ser. No. 11/132,786, filed May 18, 2005, now abandoned. U.S. application Ser. No. 11/275,630, filed Jan. 19, 2006, also claims the benefit of U.S. Provisional Application No. 60/645,819, filed Jan. 20, 2005. Each of these applications is fully incorporated by reference herein.

US Referenced Citations (328)
Number Name Date Kind
3620212 Fannon, Jr. et al. Nov 1971 A
3786806 Johnson et al. Jan 1974 A
3890977 Wilson Jun 1975 A
3974526 Dardik et al. Aug 1976 A
3995623 Blake et al. Dec 1976 A
4055861 Carpentier et al. Nov 1977 A
4164046 Cooley Aug 1979 A
4485816 Krumme Dec 1984 A
4550870 Krumme et al. Nov 1985 A
4588395 Lemelson May 1986 A
4830023 de Toledo et al. May 1989 A
5061277 Carpentier et al. Oct 1991 A
5099838 Bardy Mar 1992 A
5104404 Wolff Apr 1992 A
5197978 Hess Mar 1993 A
5250071 Palermo Oct 1993 A
5261916 Engelson Nov 1993 A
5265601 Mehra Nov 1993 A
5344426 Lau et al. Sep 1994 A
5350420 Cosgrove et al. Sep 1994 A
5411549 Peters May 1995 A
5433727 Sideris Jul 1995 A
5441515 Khosravi et al. Aug 1995 A
5449373 Pinchasik et al. Sep 1995 A
5454365 Bonutti Oct 1995 A
5458615 Klemm et al. Oct 1995 A
5474557 Mai Dec 1995 A
5507295 Skidmore Apr 1996 A
5507802 Imran Apr 1996 A
5514161 Limousin May 1996 A
5554177 Kieval et al. Sep 1996 A
5562698 Parker Oct 1996 A
5575818 Pinchuk Nov 1996 A
5584867 Limousin et al. Dec 1996 A
5601600 Ton Feb 1997 A
5609605 Marshall et al. Mar 1997 A
5617854 Munsif Apr 1997 A
5662703 Yurek et al. Sep 1997 A
5676671 Inoue Oct 1997 A
5733325 Robinson et al. Mar 1998 A
5733328 Fordenbacher Mar 1998 A
5741297 Simon Apr 1998 A
5752969 Cunci et al. May 1998 A
5800519 Sandock Sep 1998 A
5824071 Nelson et al. Oct 1998 A
5836882 Frazin Nov 1998 A
5871501 Leschinsky et al. Feb 1999 A
5891193 Robinson et al. Apr 1999 A
5895391 Farnholtz Apr 1999 A
5899882 Waksman et al. May 1999 A
5908404 Elliot Jun 1999 A
5928258 Khan et al. Jul 1999 A
5935161 Robinson et al. Aug 1999 A
5954761 Machek et al. Sep 1999 A
5961545 Lentz et al. Oct 1999 A
5978705 KenKnight et al. Nov 1999 A
5984944 Forber Nov 1999 A
6001118 Daniel et al. Dec 1999 A
6007519 Rosselli Dec 1999 A
6015402 Sahota Jan 2000 A
6022371 Killion Feb 2000 A
6027517 Crocker et al. Feb 2000 A
6045497 Schweich, Jr. et al. Apr 2000 A
6053900 Brown et al. Apr 2000 A
6056775 Borghi et al. May 2000 A
6077295 Limon et al. Jun 2000 A
6077297 Robinson et al. Jun 2000 A
6080182 Shaw et al. Jun 2000 A
6086611 Duffy et al. Jul 2000 A
6096064 Routh Aug 2000 A
6099549 Bosma et al. Aug 2000 A
6099552 Adams Aug 2000 A
6129755 Mathis et al. Oct 2000 A
6159220 Gobron et al. Dec 2000 A
6162168 Schweich, Jr. et al. Dec 2000 A
6171320 Monassevitch Jan 2001 B1
6183512 Howanec et al. Feb 2001 B1
6190406 Duerig et al. Feb 2001 B1
6200336 Pavonik et al. Mar 2001 B1
6210432 Solem Apr 2001 B1
6228098 Kayan et al. May 2001 B1
6241757 An et al. Jun 2001 B1
6254628 Wallace et al. Jul 2001 B1
6267783 Letendre et al. Jul 2001 B1
6275730 KenKnight et al. Aug 2001 B1
6306141 Jervis Oct 2001 B1
6312446 Huebsch et al. Nov 2001 B1
6334864 Amplatz et al. Jan 2002 B1
6342067 Mathis et al. Jan 2002 B1
6345198 Mouchawar et al. Feb 2002 B1
6352553 van der Burg et al. Mar 2002 B1
6352561 Leopold et al. Mar 2002 B1
6358195 Green et al. Mar 2002 B1
6368345 Dehdashtian et al. Apr 2002 B1
6395017 Dwyer et al. May 2002 B1
6402781 Langberg et al. Jun 2002 B1
6409750 Hyodoh et al. Jun 2002 B1
6419696 Ortiz et al. Jul 2002 B1
6442427 Boute et al. Aug 2002 B1
6464720 Boatman et al. Oct 2002 B2
6478776 Rosenman et al. Nov 2002 B1
6503271 Duerig et al. Jan 2003 B2
6537314 Langberg et al. Mar 2003 B2
6556873 Smits Apr 2003 B1
6562066 Martin May 2003 B1
6562067 Mathis May 2003 B2
6569198 Wilson et al. May 2003 B1
6589208 Ewers et al. Jul 2003 B2
6599311 Biggs Jul 2003 B1
6599314 Mathis et al. Jul 2003 B2
6602288 Cosgrove et al. Aug 2003 B1
6602289 Colvin et al. Aug 2003 B1
6623521 Steinke et al. Sep 2003 B2
6626899 Houser et al. Sep 2003 B2
6629534 St. Goar et al. Oct 2003 B1
6629994 Gomez et al. Oct 2003 B2
6643546 Mathis et al. Nov 2003 B2
6648881 KenKnight et al. Nov 2003 B2
6652538 Kayan et al. Nov 2003 B2
6652571 White et al. Nov 2003 B1
6656221 Taylor et al. Dec 2003 B2
6676702 Mathis Jan 2004 B2
6689164 Seguin Feb 2004 B1
6709425 Gambale et al. Mar 2004 B2
6716158 Raman et al. Apr 2004 B2
6718985 Hlavka et al. Apr 2004 B2
6721598 Helland et al. Apr 2004 B1
6723038 Schroeder et al. Apr 2004 B1
6733521 Chobotov et al. May 2004 B2
6743219 Dwyer et al. Jun 2004 B1
6764510 Vidlund et al. Jul 2004 B2
6773446 Dwyer et al. Aug 2004 B1
6776784 Ginn Aug 2004 B2
6790231 Liddicoat et al. Sep 2004 B2
6793673 Kowalsky Sep 2004 B2
6797001 Mathis et al. Sep 2004 B2
6798231 Iwasaki et al. Sep 2004 B2
6800090 Alferness et al. Oct 2004 B2
6805128 Pless et al. Oct 2004 B1
6810882 Langberg et al. Nov 2004 B2
6814752 Chuter Nov 2004 B1
6821297 Snyders Nov 2004 B2
6824562 Mathis et al. Nov 2004 B2
6827690 Bardy Dec 2004 B2
6881220 Edwin et al. Apr 2005 B2
6890353 Cohn et al. May 2005 B2
6899734 Castro et al. May 2005 B2
6908478 Alferness et al. Jun 2005 B2
6908482 McCarthy et al. Jun 2005 B2
6926690 Renati Aug 2005 B2
6935404 Duerig et al. Aug 2005 B2
6949122 Adams et al. Sep 2005 B2
6955689 Ryan et al. Oct 2005 B2
6960229 Mathis et al. Nov 2005 B2
6964683 Kowalsky et al. Nov 2005 B2
6966926 Mathis Nov 2005 B2
6976995 Mathis et al. Dec 2005 B2
7004958 Adams et al. Feb 2006 B2
7087064 Hyde Aug 2006 B1
7128073 van der Burg et al. Oct 2006 B1
7152605 Khairkhahan et al. Dec 2006 B2
7175653 Gaber Feb 2007 B2
7179282 Alferness et al. Feb 2007 B2
7270676 Alferness et al. Sep 2007 B2
7276078 Spenser et al. Oct 2007 B2
7309354 Mathis et al. Dec 2007 B2
7311729 Mathis et al. Dec 2007 B2
7316708 Gordon et al. Jan 2008 B2
7351260 Nieminen Apr 2008 B2
7364588 Mathis et al. Apr 2008 B2
7452375 Mathis et al. Nov 2008 B2
7503931 Kowalsky et al. Mar 2009 B2
7503932 Mathis Mar 2009 B2
7591826 Alferness et al. Sep 2009 B2
7608102 Adams et al. Oct 2009 B2
7635387 Reuter et al. Dec 2009 B2
7674287 Alferness et al. Mar 2010 B2
7758639 Mathis Jul 2010 B2
7794496 Gordon Sep 2010 B2
7814635 Gordon Oct 2010 B2
7828841 Mathis et al. Nov 2010 B2
7828842 Nieminen Nov 2010 B2
7828843 Alferness et al. Nov 2010 B2
7837728 Nieminen Nov 2010 B2
7837729 Gordon et al. Nov 2010 B2
7887582 Mathis et al. Feb 2011 B2
7955384 Rafiee et al. Jun 2011 B2
8006594 Hayner et al. Aug 2011 B2
8062358 Mathis et al. Nov 2011 B2
8075608 Gordon et al. Dec 2011 B2
8172898 Alferness et al. May 2012 B2
8182529 Gordon et al. May 2012 B2
8250960 Hayner et al. Aug 2012 B2
8439971 Reuter et al. May 2013 B2
8974525 Nieminen Mar 2015 B2
9320600 Nieminen Apr 2016 B2
9408695 Mathis et al. Aug 2016 B2
9474608 Mathis et al. Oct 2016 B2
9526616 Nieminen Dec 2016 B2
9597186 Nieminen Mar 2017 B2
9827098 Mathis et al. Nov 2017 B2
9827099 Mathis et al. Nov 2017 B2
9827100 Mathis et al. Nov 2017 B2
9956076 Mathis et al. May 2018 B2
9956077 Nieminen May 2018 B2
10052205 Mathis et al. Aug 2018 B2
10166102 Nieminen et al. Jan 2019 B2
10327900 Mathis et al. Jun 2019 B2
10449048 Nieminen et al. Oct 2019 B2
10456257 Mathis et al. Oct 2019 B2
10456259 Mathis et al. Oct 2019 B2
11033257 Nieminen Jun 2021 B2
11109971 Nieminen et al. Sep 2021 B2
20010018611 Solem et al. Aug 2001 A1
20010041899 Foster Nov 2001 A1
20010044568 Langberg et al. Nov 2001 A1
20010049492 Frazier Dec 2001 A1
20010049558 Liddicoat et al. Dec 2001 A1
20020010507 Ehr et al. Jan 2002 A1
20020016628 Langberg Feb 2002 A1
20020042621 Liddicoat et al. Apr 2002 A1
20020042651 Liddicoat et al. Apr 2002 A1
20020049468 Streeter et al. Apr 2002 A1
20020055774 Liddicoat May 2002 A1
20020065554 Streeter May 2002 A1
20020095167 Liddicoat et al. Jul 2002 A1
20020138044 Streeter et al. Sep 2002 A1
20020151961 Lashinski et al. Oct 2002 A1
20020156526 Hlavka et al. Oct 2002 A1
20020161377 Rabkin et al. Oct 2002 A1
20020161393 Demond et al. Oct 2002 A1
20020183837 Streeter et al. Dec 2002 A1
20020183838 Liddicoat et al. Dec 2002 A1
20020183841 Cohn et al. Dec 2002 A1
20020188170 Santamore et al. Dec 2002 A1
20020193827 McGuckin et al. Dec 2002 A1
20030018358 Saadat Jan 2003 A1
20030040771 Hyodoh et al. Feb 2003 A1
20030069636 Solem et al. Apr 2003 A1
20030078465 Pai et al. Apr 2003 A1
20030078654 Taylor et al. Apr 2003 A1
20030083613 Schaer May 2003 A1
20030088305 Van Schie et al. May 2003 A1
20030093148 Bolling et al. May 2003 A1
20030130730 Cohn et al. Jul 2003 A1
20030135267 Solem et al. Jul 2003 A1
20040019377 Taylor et al. Jan 2004 A1
20040039443 Solem et al. Feb 2004 A1
20040073302 Rourke et al. Apr 2004 A1
20040093070 Hojeibane et al. May 2004 A1
20040098116 Callas et al. May 2004 A1
20040102839 Cohn et al. May 2004 A1
20040102840 Solem et al. May 2004 A1
20040127982 Machold et al. Jul 2004 A1
20040133220 Lashinski et al. Jul 2004 A1
20040133240 Adams et al. Jul 2004 A1
20040133273 Cox Jul 2004 A1
20040138744 Lashinski et al. Jul 2004 A1
20040148019 Vidlund et al. Jul 2004 A1
20040148020 Vidlund et al. Jul 2004 A1
20040148021 Cartledge et al. Jul 2004 A1
20040153147 Mathis Aug 2004 A1
20040158321 Reuter et al. Aug 2004 A1
20040172046 Hlavka et al. Sep 2004 A1
20040176840 Langberg Sep 2004 A1
20040193191 Starksen et al. Sep 2004 A1
20040193260 Alferness et al. Sep 2004 A1
20040220654 Mathis et al. Nov 2004 A1
20040220657 Nieminen et al. Nov 2004 A1
20040243227 Starksen et al. Dec 2004 A1
20040260342 Vargas et al. Dec 2004 A1
20040260384 Allen Dec 2004 A1
20050004667 Swinford et al. Jan 2005 A1
20050027351 Reuter et al. Feb 2005 A1
20050033419 Alferness et al. Feb 2005 A1
20050060030 Lashinski et al. Mar 2005 A1
20050085903 Lau Apr 2005 A1
20050096740 Langberg et al. May 2005 A1
20050107810 Morales et al. May 2005 A1
20050137449 Nieminen et al. Jun 2005 A1
20050137450 Aronson Jun 2005 A1
20050137451 Gordon Jun 2005 A1
20050149182 Alferness et al. Jul 2005 A1
20050177228 Solem et al. Aug 2005 A1
20050197692 Pai et al. Sep 2005 A1
20050197693 Pai et al. Sep 2005 A1
20050197694 Pai et al. Sep 2005 A1
20050209690 Mathis et al. Sep 2005 A1
20050216077 Mathis et al. Sep 2005 A1
20050222678 Lashinski et al. Oct 2005 A1
20050261704 Mathis Nov 2005 A1
20050272969 Alferness et al. Dec 2005 A1
20060030882 Adams et al. Feb 2006 A1
20060041305 Lauterjung Feb 2006 A1
20060116758 Swinford et al. Jun 2006 A1
20060142854 Alferness et al. Jun 2006 A1
20060161169 Nieminen et al. Jul 2006 A1
20060167544 Nieminen et al. Jul 2006 A1
20060191121 Gordon Aug 2006 A1
20060271174 Nieminen et al. Nov 2006 A1
20070027533 Douk Feb 2007 A1
20070066879 Mathis et al. Mar 2007 A1
20070073391 Bourang et al. Mar 2007 A1
20070173926 Bobo, Jr. et al. Jul 2007 A1
20070239270 Mathis et al. Oct 2007 A1
20080015407 Mathis et al. Jan 2008 A1
20080015679 Mathis et al. Jan 2008 A1
20080015680 Mathis et al. Jan 2008 A1
20080071364 Kaye et al. Mar 2008 A1
20080221673 Bobo et al. Sep 2008 A1
20100280602 Mathis Nov 2010 A1
20110066234 Gordon et al. Mar 2011 A1
20110106117 Mathis et al. May 2011 A1
20110276120 Gilson et al. Nov 2011 A1
20120123532 Mathis May 2012 A1
20120197389 Alferness et al. Aug 2012 A1
20160310273 Nieminen Oct 2016 A1
20170189185 Nieminen et al. Jul 2017 A1
20170296341 Nieminen Oct 2017 A1
20180256330 Wypych Sep 2018 A1
20190262136 Nieminen Aug 2019 A1
20190336290 Mathis et al. Nov 2019 A1
20190350708 Mathis et al. Nov 2019 A1
20190365537 Wypych Dec 2019 A1
20200008943 Mathis et al. Jan 2020 A1
20200253732 Nieminen et al. Aug 2020 A1
20210393403 Nieminen et al. Dec 2021 A1
20230181872 Torrance et al. Jun 2023 A1
Foreign Referenced Citations (49)
Number Date Country
0893133 Jan 1999 EP
0903110 Mar 1999 EP
0968688 Jan 2000 EP
1050274 Nov 2000 EP
1095634 May 2001 EP
1177779 Feb 2002 EP
2181670 May 2010 EP
0741604 Dec 1955 GB
2754067 Mar 1998 JP
2000-308652 Nov 2000 JP
2001-503291 Mar 2001 JP
2003-503101 Jan 2003 JP
2003-521310 Jul 2003 JP
9902455 Dec 2000 SE
WO9856435 Dec 1998 WO
WO0044313 Aug 2000 WO
WO0060995 Oct 2000 WO
WO0074603 Dec 2000 WO
WO0100111 Jan 2001 WO
WO0119292 Mar 2001 WO
WO0150985 Jul 2001 WO
WO0154618 Aug 2001 WO
WO0187180 Nov 2001 WO
WO0200099 Jan 2002 WO
WO0201999 Jan 2002 WO
WO0205888 Jan 2002 WO
WO0219951 Mar 2002 WO
WO0234118 May 2002 WO
WO0247539 Jun 2002 WO
WO02053206 Jul 2002 WO
WO02060352 Aug 2002 WO
WO02062263 Aug 2002 WO
WO02062270 Aug 2002 WO
WO02062408 Aug 2002 WO
WO02076284 Oct 2002 WO
WO02078576 Oct 2002 WO
WO02096275 Dec 2002 WO
WO03015611 Feb 2003 WO
WO03037171 May 2003 WO
WO03049647 Jun 2003 WO
WO03049648 Jun 2003 WO
WO03055417 Jul 2003 WO
WO03059198 Jul 2003 WO
WO03063735 Aug 2003 WO
WO2004045463 Jun 2004 WO
WO2004084746 Oct 2004 WO
WO2005046531 May 2005 WO
WO2005058206 Jun 2005 WO
WO2006002492 Jan 2006 WO
Non-Patent Literature Citations (11)
Entry
Torrance et al.; U.S. Appl. No. 17/643,689 entitled “Modular pre-loaded medical implants and delivery systems,” filed Dec. 10, 2021.
Nieminen et al.; U.S. Appl. No. 17/655,974 entitled “Mitral valve annuloplasty device with twisted anchor,” filed Mar. 22, 2022.
El-Maasarany et al.; The coronary sinus conduit function: Anatomical study (relationship to adjacent structures); http://europace.oxfordjournals.org/cge/content/full/7/5/475. (accessed Sep. 9, 2008).
Gray, H. Anatomy of the Human Body. The Systemnic Veins. Philadelphia: Lea & Febiger, 1918; Bartleby.com. 2000. Available at www.bartleby.com/107/. Accessed Jun. 7, 2006.
Heartsite.com. Echocardiogram, 1999; p. 1-4. A.S.M. Systems Inc. Available at: http://www.heartsite.com/html/echocardiogram.html. Accessed Jul. 1, 2005.
Papageorgiou, P., et al. Coronary Sinus Pacing Prevents Induction of Atrial Fibrillation. Circulation. Sep. 16, 1997; 96(6): 1893-1898.
Pelton et al. Medical uses of nitinol; Material Science Forum; vols. 327-328; pp. 63-70; 2000 (held in Kanazawa, Japan, May 1999).
Pijls et al.; Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses; The New England J. of Med.; vol. 334; No. 26; pp. 1703-1708; Jun. 27, 1996.
Pai, Suresh; U.S. Appl. No. 60/329,694 entitled “Percutaneous cardiac support structures and deployment means,” filed Oct. 16, 2001.
Yamanouchi, et al.; Activation Mapping from the coronary sinus may be limited by anatomic variations; vol. 21 pp. 2522-2526; Nov. 1998.
Mathis et al.; U.S. Appl. No. 17/305,559 entitled “Device and method for modifying the shape of a body organ,” filed Jul. 9, 2021.
Related Publications (1)
Number Date Country
20210298732 A1 Sep 2021 US
Provisional Applications (1)
Number Date Country
60645819 Jan 2005 US
Divisions (1)
Number Date Country
Parent 16275920 Feb 2019 US
Child 17304168 US
Continuations (6)
Number Date Country
Parent 15465253 Mar 2017 US
Child 16275920 US
Parent 15136739 Apr 2016 US
Child 15465253 US
Parent 14642476 Mar 2015 US
Child 15136739 US
Parent 12907907 Oct 2010 US
Child 14642476 US
Parent 12060781 Apr 2008 US
Child 12907907 US
Parent 11275630 Jan 2006 US
Child 12060781 US
Continuation in Parts (1)
Number Date Country
Parent 11132786 May 2005 US
Child 11275630 US